The White House has withdrawn Heidi Overton’s nomination to lead the Food and Drug Administration (FDA). This decision came just before her confirmation vote, as she lacked sufficient support from Senate lawmakers.
A senior administration official informed Axios that Overton did not have the backing needed on Capitol Hill for her confirmation. A White House representative also confirmed to The Post that her nomination was officially pulled.
Overton faced bipartisan opposition from members of Congress. Her critics raised concerns due to her alleged connections with big tobacco, her support for vaping, and her anti-abortion stance. These issues contributed to resistance against her appointment.
In recent days, signs opposing Overton have been visible around Capitol Hill, including one that stated, “Say no to Heidi Vaperton,” accompanied by an image of Overton holding a vape, which had been crossed out.
The nomination process surrounded Overton with controversy due to these significant objections. Her role as a physician and deputy director of the White House Domestic Policy Council did not suffice to alleviate the concerns raised by lawmakers.
This situation continues to unfold and will require monitoring for further developments.
